Issue 2, 1997

Nuclear magnetic resonance investigations of calcium-antagonist drugs. Part 4. Conformational and dynamic features of nicardipine {methyl 2-[methyl(phenylmethyl)amino]ethyl 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)pyridine-3,5-dicarboxylate } in deuterium oxide

Abstract

Conformation and dynamics of nicardipine in deuterium oxide were investigated by 1H and 13C NMR spectroscopy. Molecular motions were characterised by effective correlation times calculated by 13C spin–lattice relaxation rates and verified by the frequency dependence of 1H spin–lattice relaxation rates or by double-selective proton relaxation rates. 1H–1H dipole–dipole connectivities were observed in 2D NOE spectra and quantified by measuring absolute values of cross-relaxation rates or by fitting the experimental 1H spin–lattice relaxation rates to a model of a sum of independent pairwise interactions. A molecular model was built showing extensive folding of the (phenylmethyl)-amino-ethyl chair and a chair conformation of the dihydropyridine moiety.

Article information

Article type
Paper

J. Chem. Soc., Perkin Trans. 2, 1997, 363-368

Nuclear magnetic resonance investigations of calcium-antagonist drugs. Part 4. Conformational and dynamic features of nicardipine {methyl 2-[methyl(phenylmethyl)amino]ethyl 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)pyridine-3,5-dicarboxylate } in deuterium oxide

L. Calzolai, E. Gaggelli, A. Maccotta and G. Valensin, J. Chem. Soc., Perkin Trans. 2, 1997, 363 DOI: 10.1039/A603846H

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Spotlight

Advertisements